# A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus

> **NCT02954601** · PHASE2 · COMPLETED · sponsor: **Oramed, Ltd.** · enrollment: 31 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ORMD-0801 (qd)
- **DRUG:** ORMD-0801 (bid)
- **DRUG:** ORMD-0801 (tid)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02954601
- **Lead sponsor:** Oramed, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-02-24
- **Final completion:** 2017-03-15
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954601, "A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02954601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*